Lymphoma is a cancer that originates in the lymphatic system, which plays a vital role in the bodys immune defense. It occurs when lymphocytes, a type of white blood cell that helps fight infections, undergo genetic changes that cause them to multiply uncontrollably and form tumors. In children, lymphoma is one of the most common types of cancer and is broadly classified into two major categories: Hodgkin lymphoma (HL) and Non-Hodgkin lymphoma (NHL). Hodgkin lymphoma typically affects adolescents and young adults, though it can occur in younger children. It is distinguished by the presence of large, abnormal cells called Reed-Sternberg cells. HL generally begins in the lymph nodes, especially in the neck or chest, and progresses in a predictable manner from one group of lymph nodes to another. Its stages range from Stage I (limited to a single lymph node region) to Stage IV, where the disease has spread to distant organs like the bone marrow, lungs, or liver. Non-Hodgkin lymphoma, in contrast, is more common in younger children and tends to be more aggressive. It can arise in lymph nodes or outside of them-in places such as the abdomen, brain, or chest and does not follow the same orderly spread as HL. NHL staging also goes from Stage I, where the disease is limited to one site, to Stage IV, where it involves multiple organs or the central nervous system. Because NHL can grow and spread quickly, early detection and prompt treatment are crucial. Despite their differences, both HL and NHL in children often respond well to treatment, which may include chemotherapy, radiation therapy, immunotherapy, or a combination of these, depending on the type and stage of the disease.

Pediatric Hodgkin and Non-Hodgkin lymphomas share several risk factors, although they differ in biology and presentation. Key risk factors include a compromised immune system-such as in children with HIV/AIDS, those on immunosuppressive therapy after organ transplantation, or those with congenital immunodeficiencies. A history of Epstein-Barr virus (EBV) infection is strongly associated with Hodgkin lymphoma, particularly the mixed cellularity subtype. Genetic predispositions, including family history of lymphoma or certain inherited syndromes, also increase risk. Environmental exposures, such as ionizing radiation or certain pesticides, have been implicated in some studies, though evidence remains inconclusive

In children, lymphoma symptoms can vary depending on whether it is Hodgkin lymphoma (HL) or Non-Hodgkin lymphoma (NHL), and the location of the disease. In Hodgkin lymphoma, one of the most common early signs is painless swelling of lymph nodes, especially in the neck, underarms, or groin. Children may also experience unexplained fevers, night sweats, fatigue, itchy skin, and unintentional weight loss. A rare but distinctive symptom is pain in the lymph nodes after consuming alcohol. If the lymphoma is located in the chest, it can cause persistent coughing, chest pain, or difficulty breathing due to pressure on the lungs or airways. In contrast, Non-Hodgkin lymphoma in children tends to progress more rapidly and may present with swollen lymph nodes that are also painless, but the symptoms often depend more on the site involved. If the abdomen is affected, children may have abdominal pain, swelling, or bloating. NHL in the chest can lead to breathing problems, chest discomfort, or a chronic cough. Systemic symptoms like fever, night sweats, weight loss, and tiredness are common in both types, but NHL may also present with lumps under the skin, and in some cases, bone or joint pain if the disease involves the bone marrow or bones. These signs can be similar to those of infections or other illnesses, so persistent or unexplained symptoms should be evaluated by a healthcare provider promptly.

Diagnosing Hodgkin lymphoma and Non-Hodgkin lymphoma in children involves a comprehensive series of steps to confirm the presence of cancer, determine its type, extent, and location, and guide treatment decisions. The process typically begins with a thorough medical history and physical examination, where the doctor assesses for enlarged lymph nodes, abdominal swelling, or skin lesions, and reviews symptoms such as fever, night sweats, fatigue, and weight loss. If lymphoma is suspected, imaging tests are conducted, including chest X-rays to detect masses, CT scans for detailed cross-sectional images of lymph nodes and organs, MRI if the brain or spinal cord may be involved, and PET scans to identify metabolically active cancerous tissue. The most definitive test for diagnosing lymphoma is a biopsy, where a sample of lymph node or tissue is examined under a microscope. This can be done through an excisional biopsy (removal of an entire lymph node), core needle biopsy, or bone marrow biopsy if there is concern that the disease has spread. Blood tests, including a complete blood count (CBC) and organ function tests, provide further insights into the childs overall health and help in treatment planning. Once lymphoma is confirmed, staging tests such as PET/CT and bone marrow aspiration determine how far the cancer has spread, while a lumbar puncture may be used if theres a risk of central nervous system involvement. It's also essential to distinguish between Hodgkin lymphoma, identified by the presence of Reed-Sternberg cells, and Non-Hodgkin lymphoma, which lacks these cells and includes various subtypes with different behaviors. In some cases, genetic and molecular testing is performed to identify specific mutations or markers that may influence treatment options, particularly for non-Hodgkin subtypes.

Treatment of lymphoma in children, whether Hodgkin lymphoma (HL) or Non-Hodgkin lymphoma (NHL), involves a comprehensive, tailored approach based on the lymphoma subtype, disease stage, and the childs overall health. For Hodgkin lymphoma, chemotherapy is the primary modality, often using combination regimens such as ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) to effectively target and destroy cancerous lymphocytes. Radiation therapy may be employed cautiously, either to treat localized tumors or as consolidation after chemotherapy, with careful attention to minimizing potential long-term side effects given the young age of patients. In cases of relapse or refractory disease, stem cell transplantation provides a means to restore healthy bone marrow following high-dose chemotherapy. Emerging targeted therapies and immunotherapies, which act on specific molecular markers or enhance the immune systems ability to attack cancer cells, offer promising options, especially for resistant or recurrent cases. For Non-Hodgkin lymphoma, treatment also centers on chemotherapy, with regimens adjusted according to whether the disease is indolent or aggressive; aggressive NHL requires more intensive chemotherapy protocols. Immunotherapy, including agents like rituximab, is increasingly integrated to improve outcomes by targeting cancer-specific antigens. Radiation therapy can be used for localized disease control or as an adjunct to chemotherapy, while stem cell transplant remains a critical option for aggressive or relapsed NHL. Although surgical intervention is rare, it may be necessary for diagnostic biopsies or tumor removal in select cases. Throughout treatment, the goal is not only to achieve remission but also to balance efficacy with minimizing acute and long-term toxicities, ensuring the best possible quality of life for pediatric patients.

Risk reduction for Hodgkin lymphoma and Non-Hodgkin lymphoma in children involves addressing modifiable factors while understanding that genetic predispositions and family history cannot be changed. Avoiding exposure to known carcinogens such as tobacco smoke including secondhand smoke and environmental chemicals like pesticides can help lower the risk of lymphoma development. Protecting children from infections linked to lymphoma, particularly viruses such as Epstein-Barr virus (EBV) and Hepatitis B, through vaccination and good hygiene practices, is also crucial. Minimizing immune suppression by carefully managing the use of immunosuppressive medications can further reduce risk. Limiting unnecessary radiation exposure, including avoiding excessive medical imaging like CT scans unless absolutely necessary, helps prevent additional risk, especially in young children who are more sensitive to radiation. Promoting a healthy lifestyle that includes a balanced diet rich in fruits and vegetables, regular physical activity, and maintaining a healthy weight can support immune function and potentially reduce cancer risk. Regular medical check-ups facilitate early detection, which significantly improves treatment outcomes, and genetic counseling is recommended for families with a history of lymphoma to assess risks and guide monitoring.

Ongoing research into pediatric Hodgkin lymphoma (HL) and Non-Hodgkin lymphoma (NHL) focuses on understanding the causes, improving treatments, enhancing early detection methods, and ultimately increasing survival rates while minimizing long-term side effects

1. What are the main differences between Hodgkin lymphoma (HL) and Non-Hodgkin lymphoma (NHL) in children? Hodgkin lymphoma usually affects older children and young adults and is identified by Reed-Sternberg cells under the microscope. Non-Hodgkin lymphoma is more common in children, lacks Reed-Sternberg cells, and often involves other organs like intestines, bone marrow, or the central nervous system. 2. How common are lymphoma cancers in children? Lymphomas are relatively rare among children, with Non-Hodgkin lymphoma being more common than Hodgkin lymphoma. Together, they make up only a small fraction of childhood cancers. 3. Is there a family history risk for lymphoma? Most pediatric lymphomas occur without a family history, but having relatives with lymphoma or other blood cancers may slightly raise the risk. Genetic factors combined with environmental or immune influences contribute to the disease. 4. What are the symptoms of pediatric lymphoma? Common symptoms include painless swelling of lymph nodes, unexplained fever, night sweats, weight loss (called B symptoms), fatigue, itchy skin or rash, and respiratory symptoms if the chest or lungs are involved. 5. How is pediatric lymphoma diagnosed? Diagnosis involves a physical exam, imaging tests (CT, MRI, PET scans), biopsy of affected lymph nodes or tissues to confirm cancer, and blood tests to assess overall health and cell abnormalities.